about
Genetic alterations in hepatocellular carcinoma: An updatePotential enhancement of intravenous nano-hydroxyapatite in high-intensity focused ultrasound ablation for treating hepatocellular carcinoma in a rabbit model.The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets.Efficacy and safety of bevacizumab for the treatment of advanced hepatocellular carcinoma: a systematic review of phase II trials.Antioxidant N-acetylcysteine attenuates hepatocarcinogenesis by inhibiting ROS/ER stress in TLR2 deficient mouse.Effect of taurine on the proliferation and apoptosis of human hepatocellular carcinoma HepG2 cells.Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cellsAnnexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cellsReduction of angiocidin contributes to decreased HepG2 cell proliferationTh22 cells are associated with hepatocellular carcinoma development and progression.Critical appraisal of ramucirumab (IMC-1121B) for cancer treatment: from benchside to clinical use.Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis.Tetrahydro Iso-Alpha Acids and Hexahydro Iso-Alpha Acids from Hops Inhibit Proliferation of Human Hepatocarcinoma Cell Lines and Reduce Diethylnitrosamine Induced Liver Tumor Formation in Rats.Clinicopathological and prognostic significance of epidermal growth factor receptor overexpression in patients with esophageal adenocarcinoma: a meta-analysis.gene function during hepatoma cells proliferation
P2860
Q28073241-8C6EF245-30A6-4B2A-B852-0E5D558AEE4EQ30439735-C0D9AF2C-188A-4773-8CB4-758DFED1CB20Q34182483-C7B732D3-D23B-48EE-B8E1-6259B1D81695Q34531474-D2F3CE34-AC64-4386-A786-5DDD74F9C96BQ35008938-DECF0B75-8CA5-47BE-B629-876C05A850E3Q35802713-710E5901-769B-4997-AA0F-4892C197F775Q36592526-1F05F7F1-85B1-4D44-88A3-6020886444DAQ36975026-C015C876-65D6-4FF7-98A7-901CDAF4D9FEQ37298953-A14C2D40-CD46-4874-99E1-BE6EE91486DCQ37725429-435889E8-9A65-459C-96A3-83719EB7968EQ38166329-C23899DE-76DB-4105-A713-FB9F0492BC25Q38235254-F34DC985-8CB3-4F18-B9BC-6B21B2C1816CQ38878979-7A53099B-E5D1-4B96-AAA4-E4E11D8E7B7AQ54342465-8C8D3BD6-B43D-45BD-BB5F-B0AA05477B54Q58697722-35EAD364-C4E7-433A-A8A2-EEE4D76B6DA7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Signaling pathways in hepatocellular carcinoma.
@en
Signaling pathways in hepatocellular carcinoma.
@nl
type
label
Signaling pathways in hepatocellular carcinoma.
@en
Signaling pathways in hepatocellular carcinoma.
@nl
prefLabel
Signaling pathways in hepatocellular carcinoma.
@en
Signaling pathways in hepatocellular carcinoma.
@nl
P2860
P356
P1433
P1476
Signaling pathways in hepatocellular carcinoma
@en
P2093
Daniela Sia
P2860
P356
10.1159/000333254
P478
81 Suppl 1
P577
2011-12-22T00:00:00Z